Pavitra Keshavan

797 total citations
15 papers, 614 citations indexed

About

Pavitra Keshavan is a scholar working on Epidemiology, Microbiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Pavitra Keshavan has authored 15 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Microbiology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Pavitra Keshavan's work include Pneumonia and Respiratory Infections (10 papers), Bacterial Infections and Vaccines (10 papers) and Influenza Virus Research Studies (4 papers). Pavitra Keshavan is often cited by papers focused on Pneumonia and Respiratory Infections (10 papers), Bacterial Infections and Vaccines (10 papers) and Influenza Virus Research Studies (4 papers). Pavitra Keshavan collaborates with scholars based in United States, Netherlands and Italy. Pavitra Keshavan's co-authors include Stephen D. Zucker, Sandy Schwemberger, George F. Babcock, Darcey L.H. Smith, Kenneth E. Sherman, Richard M. Green, Judith Feinberg, Fei Yu, Xiaofa Qin and Susan D. Rouster and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

Pavitra Keshavan

15 papers receiving 604 citations

Peers

Pavitra Keshavan

PPCH

EPIDE

MICRO

Yin Ping Wong Malaysia

William M. O’Neil Canada

Olena Kis Canada

Maria Grazia Marazzi Italy

Denis Hochstrasser Switzerland

Ton-Ho Young Taiwan

Benno Schnyder Switzerland

Thao Doan United States

Ágota Kovács Hungary

Johny E. Elkahwaji United States

Yin Ping Wong Malaysia

Pavitra Keshavan

155 ×0.6

89 ×0.5

PPCH

146 ×0.8

EPIDE

32 ×0.3

MICRO

24 ×0.3

Citations per year, relative to Pavitra Keshavan Pavitra Keshavan (= 1×) peers Yin Ping Wong

Countries citing papers authored by Pavitra Keshavan

Since Specialization

Citations

This map shows the geographic impact of Pavitra Keshavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavitra Keshavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavitra Keshavan more than expected).

Fields of papers citing papers by Pavitra Keshavan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavitra Keshavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavitra Keshavan. The network helps show where Pavitra Keshavan may publish in the future.

Co-authorship network of co-authors of Pavitra Keshavan

This figure shows the co-authorship network connecting the top 25 collaborators of Pavitra Keshavan. A scholar is included among the top collaborators of Pavitra Keshavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavitra Keshavan. Pavitra Keshavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vesikari, Timo, Jerzy Brzostek, Marita Paassilta, et al.. (2021). Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents. Human Vaccines & Immunotherapeutics. 17(11). 4689–4700. 7 indexed citations

Giuliani, Marzia Monica, Alessia Biolchi, Pavitra Keshavan, et al.. (2020). Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children. Human Vaccines & Immunotherapeutics. 17(5). 1442–1449. 1 indexed citations

Klein, Nicola P., et al.. (2019). Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods. Vaccine. 37(32). 4460–4467. 5 indexed citations

Senders, Shelly, et al.. (2019). MenACWY-CRM conjugate vaccine booster dose given 4–6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults. Vaccine. 37(42). 6171–6179. 9 indexed citations

Keshavan, Pavitra, et al.. (2018). An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine. Expert Review of Vaccines. 17(10). 865–880. 21 indexed citations

Sáez‐Llorens, Xavier, et al.. (2018). Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults. Human Vaccines & Immunotherapeutics. 14(5). 1161–1174. 16 indexed citations

Baxter, Roger, Pavitra Keshavan, Jo Anne Welsch, Linda K. Han, & Igor Smolenov. (2016). Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants. Human Vaccines & Immunotherapeutics. 12(5). 1300–1310. 28 indexed citations

Block, Stan L., Bikash Verma, Fang Xie, et al.. (2015). Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination. Vaccine. 33(18). 2175–2182. 16 indexed citations

Johnston, William, Brandon Essink, Judith L. Kirstein, et al.. (2015). Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age. The Pediatric Infectious Disease Journal. 35(1). e19–e27. 7 indexed citations

10.

Gasparini, Roberto, Miguel Tregnaghi, Pavitra Keshavan, et al.. (2015). Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration. The Pediatric Infectious Disease Journal. 35(1). 81–93. 17 indexed citations

11.

Smith, Darcey L.H., et al.. (2010). Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor. Carcinogenesis. 31(6). 1100–1109. 27 indexed citations

12.

Chen, Michael C., et al.. (2007). RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis. American Journal of Physiology-Renal Physiology. 292(5). F1372–F1379. 32 indexed citations

13.

Keshavan, Pavitra, Tracy L. Deem, Sandy Schwemberger, et al.. (2005). Unconjugated Bilirubin Inhibits VCAM-1-Mediated Transendothelial Leukocyte Migration. The Journal of Immunology. 174(6). 3709–3718. 136 indexed citations

14.

Keshavan, Pavitra, Sandy Schwemberger, Darcey L.H. Smith, George F. Babcock, & Stephen D. Zucker. (2004). Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. International Journal of Cancer. 112(3). 433–445. 103 indexed citations

15.

Zucker, Stephen D., Xiaofa Qin, Susan D. Rouster, et al.. (2001). Mechanism of indinavir-induced hyperbilirubinemia. Proceedings of the National Academy of Sciences. 98(22). 12671–12676. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact